Hosted on MSN
A True Game-Changer in Prostate Cancer: A Simple Genomic Test Can Tell Us Who Needs Hormone Therapy And Who Doesn’t
If you or a loved one are navigating the journey of prostate cancer, you know that every decision weighs heavily. You’ve likely faced surgery or initial treatments, only to encounter the fear that ...
The NRG Oncology NRG-GU009 (PREDICT-RT) study evaluating intensified and de-intensified concurrent radiation regimens based on the genomic risk of patients with high-risk prostate cancer completed ...
Clinical Implementation of Expanded Solid Tumor Fusion Detection With Whole-Transcriptome Sequencing at an Academic Cancer Center One hundred twenty-two participants completed the survey. The majority ...
TARGETED treatments for prostate cancer were a central theme at the European Society for Medical Oncology (ESMO) Congress ...
For Josh Henderson, 66, of Olympia, getting genetic testing was a no-brainer. “The first time I came to Fred Hutch, my oncologist suggested it,” said the retired IT manager who received a metastatic ...
Please provide your email address to receive an email when new articles are posted on . Black men with prostate cancer had significantly greater odds of having alterations in immunotherapy targets ...
Mass population testing for prostate cancer will not see men proactively invited for the PSA blood test - here is all you need to know about who can get checked ...
The assay detects aggressive prostate tumors in men on active surveillance for low-risk cancer, potentially helping them ...
4hon MSN
Cancer surgeon breaks down 5 biggest myths about prostate cancer: What every man over 40 should know
A surgeon outlines five important prostate cancer myths that men over 40 should know for early detection and treatment.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results